UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Trajan Wealth LLC

Trajan Wealth LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 39,047 shares of the healthcare conglomerate's stock after purchasing an additional 4,747 shares during the period. UnitedHealth Group comprises approximately 1.1% of Trajan Wealth LLC's holdings, making the stock its 22nd biggest position. Trajan Wealth LLC's holdings in UnitedHealth Group were worth $19,752,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.7 %

NYSE:UNH traded down $2.84 during trading hours on Thursday, reaching $425.13. The company's stock had a trading volume of 3,642,925 shares, compared to its average volume of 5,627,220. UnitedHealth Group Incorporated has a 12 month low of $417.12 and a 12 month high of $630.73. The stock has a 50 day moving average price of $506.92 and a two-hundred day moving average price of $537.23. The company has a market capitalization of $388.87 billion, a P/E ratio of 27.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm posted $6.91 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.98%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Analyst Ratings Changes

Several brokerages have commented on UNH. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Erste Group Bank upgraded UnitedHealth Group to a "strong-buy" rating in a report on Wednesday, April 16th. Oppenheimer lowered their target price on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday. Raymond James reaffirmed a "strong-buy" rating and set a $540.00 price target (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday. Finally, Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of "Buy" and an average target price of $603.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.